undamentalytics Newsletter

Saeli Thomas Louis: insider trades

Director at Ultralife Corp. 9 open-market purchases and no sales not made under a pre-set plan, reported from March 4, 2013 to May 14, 2025.

Would copying Saeli Thomas Louis’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 5 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 26, 2017 into $33,092 by November 2, 2026, +13.6% a year. The copy held shares only 48% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $24,000, +9.8% a year (the S&P 500 held throughout made $36,275, +14.7% a year). Beta against the index was 0.20. Twelve months after each report, the average purchase was +14.8% against the S&P 500 (median +6.3%), and 60% beat it. Measured from the trade date, the insider’s own timing, the average was +4.7%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 20172019202120232025 $36.3k$33.1k$24.0k
Copying Saeli Thomas LouisS&P 500, same days investedS&P 500, held throughout $10,000 copying Saeli Thomas Louis’s open-market purchases from May 26, 2017, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+13.6%
S&P 500, same days invested
+9.8% (held throughout +14.7%)
Time in shares
48%
Sharpe ratio (S&P 500)
0.44 (0.69)
Biggest drop (S&P 500)
−45% (−34%)
Market sensitivity (beta)
0.20
Purchases copied
5

Trade by trade

Saeli Thomas Louis: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 5 +29.0% +1.6% 80% 4 1.31 0.28 No reliable evidence
Purchases, 6 months after the report 5 −2.2% −4.7% 40% 4 0.03 0.98 No reliable evidence
Purchases, 12 months after the report 5 +14.8% +6.3% 60% 4 0.92 0.42 No reliable evidence
Purchases, 12 months after the trade 4 +4.7% −4.8% 50% 3 — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Ultralife Corp ULBI —90March 4, 2013May 14, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 14, 2025May 14, 2025 ULBI Purchase $27,200 +0.7%−23.5%−17.3%
June 14, 2023June 13, 2023 ULBI Purchase $22,633 +100.9%+73.2%not yet
March 8, 2023March 7, 2023 ULBI Purchase $20,250 not yetnot yetnot yet
May 3, 2022May 3, 2022 ULBI Purchase $48,900 not yetnot yetnot yet
November 15, 2018November 14, 2018 ULBI Purchase $14,120 +42.2%+6.4%+6.5%
May 14, 2018May 11, 2018 ULBI Purchase $20,350 −0.5%−22.5%−16.0%
May 25, 2017May 24, 2017 ULBI Purchase $23,200 +1.6%+40.2%+45.5%
February 26, 2015February 25, 2015 ULBI Purchase $11,779 not yetnot yetnot yet
March 4, 2013February 28, 2013 ULBI Purchase $10,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Saeli Thomas Louis traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.